Interim FDG-PET improves treatment failure prediction in primary central nervous system Lymphoma: a LOC network prospective multicentric study.

Laura RozenblumCaroline HouillierAmandine BaptisteCarole SoussainVéronique EdelinePhilippe NaggaraMarine SoretValérie Causse-LemercierLise WillemsSylvain ChoquetRenata UrsuDamien GalanaudLisa BelinKhê Hoang-XuanAurélie Kas

Published in: Neuro-oncology (2024)

Our study highlights the potential of interim FDG-PET for early management of PCNSL patients. Response-driven treatment based on PET2 may guide future clinical trials.

Keyphrases

pet ct
positron emission tomography
pet imaging
clinical trial
computed tomography
ejection fraction
end stage renal disease
newly diagnosed
randomized controlled trial
diffuse large b cell lymphoma
risk assessment
study protocol